Scioderm, Inc., an Amicus Therapeutics Company

📍 Durham, United States🗓 Founded 2012👥 2 employees💰 Last funded Oct 2013
Biotechnology🌐 sderm.com
Website LinkedIn
Scioderm, Inc. was acquired by Amicus Therapeutics, Inc. in September of 2015. Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare genetic diseases. Amicus, together with Scioderm, was developing an investigational topical treatment (SD-101) for people with Epidermolysis Bullosa (EB), which is a rare genetic connective tissue disorder. In September of 2017, results of a Phase 3 clinical study to assess the efficacy and safety of SD-101, showed that it did not show a statistically significant difference from placebo. Subsequently, Amicus discontinued the program, but shared the clinical data and additional information related to the EB program with key stakeholders including other companies with investigational treatments for EB as well as the broader EB community.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Scioderm, Inc., an Amicus Therapeutics Company?
Scioderm, Inc., an Amicus Therapeutics Company has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Scioderm, Inc., an Amicus Therapeutics Company last raise funding?
The most recent investment in Scioderm, Inc., an Amicus Therapeutics Company recorded on gritt.io was in October 2013.
When was Scioderm, Inc., an Amicus Therapeutics Company founded?
Scioderm, Inc., an Amicus Therapeutics Company was founded in 2012.
What industry is Scioderm, Inc., an Amicus Therapeutics Company in?
Scioderm, Inc., an Amicus Therapeutics Company operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Scioderm, Inc., an Amicus Therapeutics Company based?
Scioderm, Inc., an Amicus Therapeutics Company is headquartered in Durham, United States.